Clinical Trials Browser

INDUSTRY × Interventional × HER2 Positive Breast Cancer × Clear all

NCT02476539 2024-03-01

Study Evaluating Hemay022 In Subjects With HER2-Positive Advanced Breast Cancer

Phase 1 Completed

HER2 Positive Breast Cancer